Vio Chemicals AG

Based in Zurich, Switzerland, and founded in 2001 by Dimitris Kalias, Vio Chemicals AG operates as a chemical-based company providing and developing a variety of chemical products such as amino acid derivatives, chiral ligands, and pyrimidine derivatives. In December 2023, Carbosynth Limited, a portfolio company of KKR and Ampersand Capital Partners, acquired Vio Chemicals AG. Vio Chemicals AG produces a wide range of products, including intermediates for api synthesis, drug formulation excipients, nucleotides, nucleosides and related chemicals, organophosphorus products, amino acid derivatives, chiral intermediates, chiral ligands, fluorinated aromatics, benzene ring derivatives, pyridine derivatives, piperidine derivatives, pyrimidine derivatives, bile acids and derivatives, chloroformates, isocyanates, and many more. The company offers a variety of services, such as research and development, manufacturing, procurement and supply chain, integrated support, and consultancy.